A chemotyping scheme for clinical isolates of Haemophilus influenzae.
A total of 464 Haemophilus influenzae strains, most of them fresh clinical isolates, have been classified by chemotyping --a combination of auxotyping and biotyping. Seven auxotests and four other biochemical tests allowed recognition of 56 types. These were to a degree site-specific. H. influenzae of capsular type b proved almost without exception to belong to one chemotype, and 24 of 33 strains assigned to this chemotype were capsulated. When surgical-ward isolates of H. influenzae were typed, the results suggested that some cross-infection had occurred.
D000596:Amino Acids / Q000494:pharmacology; D003470:Culture Media; D004423:Ear / Q000382:microbiology; D005123:Eye / Q000382:microbiology; D005260:Female; D006192:Haemophilus Infections / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000145:classification* / Q000254:growth & development / Q000302:isolation & purification; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000494:pharmacology; D009666:Nose / Q000382:microbiology; D010256:Paranasal Sinuses / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D013936:Thymidine / Q000494:pharmacology; D014621:Vagina / Q000382:microbiology
D000596:Amino Acids; D003470:Culture Media; D007042:Hypoxanthines; D019271:Hypoxanthine; D013936:Thymidine